These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 22661183

  • 1. Synthesis, anticonvulsant activity and 5-HT1A/5-HT7 receptors affinity of 1-[(4-arylpiperazin-1-yl)-propyl]-succinimides.
    Obniska J, Chlebek I, Kamiński K, Bojarski AJ, Satała G.
    Pharmacol Rep; 2012; 64(2):326-35. PubMed ID: 22661183
    [Abstract] [Full Text] [Related]

  • 2. Synthesis, anticonvulsant activity and 5-HT1A, 5-HT2A receptor affinity of new N-[(4-arylpiperazin-1-yl)-alkyl] derivatives of 2-azaspiro[4.4]nonane and [4.5]decane-1,3-dione.
    Obniska J, Kołaczkowski M, Bojarski AJ, Duszyńska B.
    Eur J Med Chem; 2006 Jul; 41(7):874-81. PubMed ID: 16600439
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and anticonvulsant activity of new 1-[2-oxo-2-(4-phenylpiperazin-1-yl)ethyl]pyrrolidine-2,5-diones.
    Kamiński K, Rzepka S, Obniska J.
    Bioorg Med Chem Lett; 2011 Oct 01; 21(19):5800-3. PubMed ID: 21875804
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and anticonvulsant properties of new Mannich bases derived from 3-aryl-pyrrolidine-2,5-diones. Part 1.
    Obniska J, Kopytko M, Zagórska A, Chlebek I, Kamiński K.
    Arch Pharm (Weinheim); 2010 Jun 01; 343(6):333-41. PubMed ID: 20379970
    [Abstract] [Full Text] [Related]

  • 5. Synthesis, anticonvulsant properties and 5-HT1A/5-HT2A receptor affinity of new N-[(4-arylpiperazin-1-yl)-propyl]-2-aza-spiro[4.4]nonane and [4.5]decane-1,3-dione derivatives.
    Obniska J, Kołaczkowski M, Charakchieva-Minol S, Nedza K, Dybała M, Bojarski AJ.
    Pharmacol Rep; 2005 Jun 01; 57(3):336-44. PubMed ID: 15985716
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and anticonvulsant activity of new N-[(4-arylpiperazin-1-yl)-alkyl] derivatives of 3-phenyl-pyrrolidine-2,5-dione.
    Obniska J, Kaminski K, Skrzynska D, Pichor J.
    Eur J Med Chem; 2009 May 01; 44(5):2224-33. PubMed ID: 18603334
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and anticonvulsant properties of new mannich bases derived from 3,3-disubstituted pyrrolidine-2,5-diones. Part IV.
    Obniska J, Chlebek I, Kamiński K.
    Arch Pharm (Weinheim); 2012 Sep 01; 345(9):713-22. PubMed ID: 22674811
    [Abstract] [Full Text] [Related]

  • 8. Synthesis, physicochemical and anticonvulsant properties of new N-[(4-arylpiperazin-1-yl)alkyl]-3-phenyl- and 3-(3-methyl-phenyl)-pyrrolidine-2,5-diones.
    Obniska J, Chlebek I, Pichór J, Kopytko M, Kamiński K.
    Acta Pol Pharm; 2009 Sep 01; 66(6):639-47. PubMed ID: 20050528
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and biological properties of new N-Mannich bases derived from 3-methyl-3-phenyl- and 3,3-dimethyl-succinimides. Part V.
    Kamiński K, Obniska J, Chlebek I, Liana P, Pękala E.
    Eur J Med Chem; 2013 Aug 01; 66():12-21. PubMed ID: 23777899
    [Abstract] [Full Text] [Related]

  • 10. Design and synthesis of new of 3-(benzo[d]isoxazol-3-yl)-1-substituted pyrrolidine-2, 5-dione derivatives as anticonvulsants.
    Malik S, Ahuja P, Sahu K, Khan SA.
    Eur J Med Chem; 2014 Sep 12; 84():42-50. PubMed ID: 25014748
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and anticonvulsant properties of new N-Mannich bases derived from 3,3-diphenyl- and 3-ethyl-3-methyl-pyrrolidine-2,5-diones. Part III.
    Obniska J, Chlebek I, Kamiński K, Karolak-Wojciechowska J.
    Arch Pharm (Weinheim); 2013 Jan 12; 346(1):71-82. PubMed ID: 23180594
    [Abstract] [Full Text] [Related]

  • 12. Design, synthesis and biological activity of new amides derived from 3-methyl-3-phenyl-2,5-dioxo-pyrrolidin-1-yl-acetic acid.
    Obniska J, Rapacz A, Rybka S, Powroźnik B, Pękala E, Filipek B, Żmudzki P, Kamiński K.
    Eur J Med Chem; 2015 Sep 18; 102():14-25. PubMed ID: 26241874
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and anticonvulsant properties of new N-[(4-arylpiperazin-1-yl)-methyl] derivatives of 3-aryl pyrrolidine-2,5-dione and 2-aza-spiro[4.4]nonane-1,3-dione.
    Obniska J, Zagorska A.
    Farmaco; 2003 Dec 18; 58(12):1227-34. PubMed ID: 14630232
    [Abstract] [Full Text] [Related]

  • 14. Anticonvulsant properties of N-(4-methylpiperazin-1-yl)- and N-[3-(4-methyl-piperazin-1-yl)propyl] derivatives of 3-aryl- and 3-spirocycloalkyl-pyrrolidine-2,5-dione.
    Obniska J, Jurczyk S, Zejc A, Kamiński K, Tatarczyńska E, Stachowicz K.
    Pharmacol Rep; 2005 Dec 18; 57(2):170-5. PubMed ID: 15886415
    [Abstract] [Full Text] [Related]

  • 15. Design and synthesis of some new 1-phenyl-3/4-[4-(aryl/heteroaryl/alkyl-piperazine1-yl)-phenyl-ureas as potent anticonvulsant and antidepressant agents.
    Mishra CB, Kumari S, Tiwari M.
    Arch Pharm Res; 2016 May 18; 39(5):603-17. PubMed ID: 26891908
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Synthesis and evaluation of pharmacological properties of some new xanthone derivatives with piperazine moiety.
    Waszkielewicz AM, Gunia A, Szkaradek N, Pytka K, Siwek A, Satała G, Bojarski AJ, Szneler E, Marona H.
    Bioorg Med Chem Lett; 2013 Aug 01; 23(15):4419-23. PubMed ID: 23787101
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and Determination of Lipophilicity, Anticonvulsant Activity, and Preliminary Safety of 3-Substituted and 3-Unsubstituted N-[(4-Arylpiperazin-1-yl)alkyl]pyrrolidine-2,5-dione Derivatives.
    Rybka S, Obniska J, Żmudzki P, Koczurkiewicz P, Wójcik-Pszczoła K, Pękala E, Bryła A, Rapacz A.
    ChemMedChem; 2017 Nov 22; 12(22):1848-1856. PubMed ID: 29045762
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.